» Articles » PMID: 24628402

A Review of Pharmacokinetic Parameters of Metabolites and Prodrugs

Overview
Journal Drug Metab Lett
Date 2014 Mar 18
PMID 24628402
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In drug discovery and development, the kinetic study of active metabolites plays an important role, helping to define the time course of the drug in the body and its activity or toxicity. After a pharmacokinetics assessment of a drug and its metabolite or a prodrug and its parent-drug, several parameters can be calculated. In some cases, achieving the objective of the study does not require all possible parameters to be calculated. When parameters are calculated, it is essential that their denotations are widely accepted and used. However, some parameters undergo a certain variability of denotation, which may confuse some readers. Thus, this review summarizes the current published data for experimental pharmacokinetic parameters of metabolites and the calculations involved in simple metabolite pharmacokinetic studies. It also evaluates the most common pharmacokinetic parameters in the literature and suggests metabolite parameters that could be determined to help advance metabolite kinetic models.

Citing Articles

Development of a metabolomics-based data analysis approach for identifying drug metabolites based on high-resolution mass spectrometry.

Ting H, Chiou Y, Chang T, Lin G, Li P, Shih C J Food Drug Anal. 2023; 31(1):152-164.

PMID: 37224561 PMC: 10208669. DOI: 10.38212/2224-6614.3451.


First-In-Human Study on Pharmacokinetics, Safety, and Tolerability of Single and Multiple Escalating Doses of Hepenofovir, a Novel Hepatic Targeting Prodrug of Tenofovir in Healthy Chinese Subjects.

Zhang H, Gao L, Lou J, Wu M, Chen H, Yang L Front Pharmacol. 2022; 13:873588.

PMID: 35662718 PMC: 9161552. DOI: 10.3389/fphar.2022.873588.


Understanding the pharmacokinetics of reversible metabolism.

Cho S, Yoon Y Transl Clin Pharmacol. 2020; 27(2):52-58.

PMID: 32055581 PMC: 6989244. DOI: 10.12793/tcp.2019.27.2.52.


Understanding the pharmacokinetics of prodrug and metabolite.

Cho S, Yoon Y Transl Clin Pharmacol. 2020; 26(1):1-5.

PMID: 32055540 PMC: 6989223. DOI: 10.12793/tcp.2018.26.1.1.